You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ACE-LY-106

Showing 1 - 25 of 1,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Adenocarcinoma Trial in Guangzhou (Sintilimab, Ramucirumab, Cisplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 10, 2022

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston

Active, not recruiting
  • Metastatic Urothelial Carcinoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

MDS Trial in China, Japan (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
  • +33 more
Aug 16, 2022

Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

Recruiting
  • Hypertension
  • +17 more
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Jan 3, 2023

    Erythrocyte Transfusion, Beta-Thalassemia Trial in Worldwide (Luspatercept, Placebo)

    Completed
    Has Results
    • Erythrocyte Transfusion
    • Beta-Thalassemia
    • Los Angeles, California
    • +72 more
    Jan 21, 2022

    Musculoskeletal Diseases Trial in Lincoln (ACE-083)

    Completed
    Has Results
    • Musculoskeletal Diseases
    • Lincoln, Nebraska
      Acceleron Investigative Site
    Sep 12, 2022

    Exercise Performance Trial in Tainan (Placebo, Probiotic 1,Lactococcus lactis subsp. lactis, LY-66, Probiotic 2,Lactobacillus

    Completed
    • Exercise Performance
    • Placebo
    • +3 more
    • Tainan, Taiwan
      Glac Biotech Co., Ltd.
    Oct 15, 2023

    Hepatocellular Carcinoma Trial in Kaohsiung, Tainan, Taipei (T-ACE Oil, Lipiodol)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Kaohsiung, Taiwan
    • +2 more
    Jul 11, 2022

    Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Phoenix, Arizona
    • +137 more
    Jan 27, 2023

    Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)

    Not yet recruiting
    • Myasthenia Gravis
    • +3 more
    • Chicago, Illinois
      Research Site
    Oct 30, 2023

    Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

    Not yet recruiting
    • Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
    • +2 more
    • INZ-701
    • Control Arm (Conventional Therapy)
    • (no location specified)
    Sep 18, 2023

    Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • PK Blood Collection
    • +2 more
    • (no location specified)
    Nov 1, 2022

    Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)

    Recruiting
    • Breast Feeding
    • +3 more
    • Venipuncture
    • Leuven, Vlaams-Brabant, Belgium
      Universitaire Ziekenhuizen Leuven
    Oct 12, 2023

    Adolescent Behavior, Nutrition, Healthy Trial in Ithaca (ACE intervention)

    Active, not recruiting
    • Adolescent Behavior
    • Nutrition, Healthy
    • ACE intervention
    • Ithaca, New York
      Cornell University
    Jun 22, 2023

    Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

    Recruiting
    • Lymphoma, Mantle Cell
    • Downey, California
    • +231 more
    Jan 16, 2023

    Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Daratumumab, Pomalidomide)

    Not yet recruiting
    • Relapsed or Refractory Multiple Myeloma
    • Tucson, Arizona
    • +191 more
    Aug 11, 2022

    MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Luspatercept
    • Epoetin Alfa
    • Concord, California
    • +100 more
    Jul 20, 2023

    Solid Tumor Trial in Denver, Fairfax (PYX-106)

    Recruiting
    • Solid Tumor
    • Denver, Colorado
    • +1 more
    Feb 9, 2023

    Solid Tumor Trial in Shanghai (AB-106, digoxin)

    Completed
    • Solid Tumor
    • AB-106, digoxin
    • Shanghai, China
      Shanghai Xuhui Central Hospital
    May 5, 2022

    Solid Tumor Trial in Beijing (AB-106, Itraconazole, AB-106, Rifampicin)

    Completed
    • Solid Tumor
    • AB-106, Itraconazole
    • AB-106, Rifampicin
    • Beijing, China
      Xuanwu Hospital of Capital Medical University
    Apr 27, 2022

    Auditory Hallucinations Trial in Pittsburgh (Transcranial Direct Current Stimulation (tDCS), Auditory Cognitive Control Training

    Recruiting
    • Auditory Hallucinations
    • Transcranial Direct Current Stimulation (tDCS)
    • Auditory Cognitive Control Training (ACCT)
    • Pittsburgh, Pennsylvania
      Western Psychiatric Hospital of UPMC
    Nov 30, 2023

    Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • Hypertension
    • Placebo
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University
    Feb 8, 2022

    Follicular B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Recurrent, Mantle Cell Lymphoma Refractory Trial in Orange,

    Recruiting
    • Follicular B-cell Non-Hodgkin's Lymphoma
    • +7 more
    • MB-106
    • Orange, California
    • +3 more
    Nov 1, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Taletrectinib)

    Recruiting
    • Non Small Cell Lung Cancer
    • Beverly Hills, California
    • +58 more
    Dec 13, 2022